NL-OMON51918RecruitingNot Applicable
ongitudinal prediction of progression in MS: The PrograMS Cohort - PrograMS
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Recruiting
- Enrollment
- 300
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
- Ages
- 18 to 99 (—)
Inclusion Criteria
- •All people with MS and all healthy controls (HC) who have previously
- •participated in the Presto (2002/140), GeneOCT(2004/9), or LTD (2010/336)
- •studies (collectively also known as *PrograMS*) and have not provided objection
- •to be contacted for follow-up study, or have been enquired to join the cohort
- •based on the Amsterdam MS Cohort (2020/269) protocol.
Exclusion Criteria
- •A potential subject who meets any of the following criteria will be excluded
- •from participation in this study:
- •MS patients:
- •- Persons unable to undergo the minimal data collection (as described in
- •Methods section)
- •- Comorbidity that interferes with participation in this study
Investigators
Similar Trials
Recruiting
Not Applicable
PrograMSMultiple SclerosisNL-OMON21916VU University Medical Center260
Active, not recruiting
Unknown
Identifying genetic determinants of outcome in multiple sclerosisNervous System DiseasesMultiple sclerosisISRCTN41688895Cambridge University Hospitals NHS Foundation Trust10,000
Completed
Not Applicable
Does MS grey matter atrophy progress faster in regions with more damage in connected white matter?10012303multiple sclerosisNL-OMON43307Vrije Universiteit Medisch Centrum55
Completed
Not Applicable
Predictive markers for progessive disease progression in Acne Inversa (AI)/Hidradentitis Suppurativa (HS) patientsACNEINVERSAL73L73.2Other follicular disordersHidradenitis suppurativaDRKS00013778AbbVie Deutschland GmbH Co. KG481
Completed
Not Applicable
Assessment of the prognostic value of MM related bone disease as detected by Whole Body X Ray (WBXR), Whole Body - Magnetic Resonance Imaging (WB-MRI) and FluoroDeoxyGlucose - Positron Emission Tomography - Computer Tomography (FDG-PET-CT) at diagnosis (part I) and in follow-up (part II)Kahler's disease10035227Multiple MyelomaNL-OMON36434HOVO60